Jacqueline Dedo - Feb 22, 2023 Form 4 Insider Report for Workhorse Group Inc. (WKHS)

Role: Director
Signature: /s/ Arthur McMahon, attorney-in-fact for Jacqueline A. Dedo
Stock symbol: WKHS
Transactions as of: Feb 22, 2023
Transactions value $: $100,000
Form type: 4
Date filed: 2/24/2023, 05:57 PM
Previous filing: Dec 13, 2022
Next filing: Dec 29, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WKHS	Common Stock, $0.001 par value per share	Award	$100K	+49.5K	+49.05%	$2.02	150K	Feb 22, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock granted by Workhorse Group Inc. (the "Company") under a Restricted Stock Award Agreement, vesting on August 22, 2023; provided, if the reporting person is no longer a director of the Company on August 23, 2023 by reason of death, disability, or not standing for re-election, will vest pro rata based on the number of board meetings attended by the grantee in 2023 as compared to the total number of scheduled board meetings in 2023 between the grant date and the six-month anniversary thereof. The stock price reflected in Table I Column 4 was determined based on fair market value as the closing trading price of the Company's common stock on the trading day immediately prior to the grant date.

Content

Represents shares of common stock granted by Workhorse Group Inc. (the "Company") under a Restricted Stock Award Agreement, vesting on August 22, 2023; provided, if the reporting person is no longer a director of the Company on August 23, 2023 by reason of death, disability, or not standing for re-election, will vest pro rata based on the number of board meetings attended by the grantee in 2023 as compared to the total number of scheduled board meetings in 2023 between the grant date and the six-month anniversary thereof. The stock price reflected in Table I Column 4 was determined based on fair market value as the closing trading price of the Company's common stock on the trading day immediately prior to the grant date.